Oxidized low-density lipoprotein acts synergistically with β-glycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells

Journal of Cellular Biochemistry

Volumn 105, Issue 1, 2008, Pages 185-193

  Bear, Mackenzie ^a   Butcher, Martin ^a   Shaughnessy, Stephen G ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HENDERSON RESEARCH CENTRE   (Canada)

Author keywords

Osteoblast differentiation; Osterix; Oxidized low density lipoprotein; Smooth muscle cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALKALINE PHOSPHATASE; GLYCEROL 2 PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OXIDIZED LOW DENSITY LIPOPROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; AORTA; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; CATTLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; OSTEOBLAST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; CATTLE; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DRUG SYNERGISM; GLYCEROPHOSPHATES; LIPOPROTEINS, LDL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOBLASTS; RNA, SMALL INTERFERING; SMAD PROTEINS;

BOVINAE;

EID: 51849153694     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21812     Document Type: Article

References (45)

1. Acampora D, Merlo G, Paleari L, Serega B, Postiglione M, Mantero S, Bober E, Barbieri O, Simeone A, Levi G. 1999. Craniofacial, vestibular and bone defects in mice lacking the distal-less-related gene Dlx5. Development 126:3795-3809.
2. Afzal F, Pratap J, Ito K, Ito Y, Stein JL, Van Wijnen AJ, Stein G, Lian JB, Javed A. 2005. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol 204:63-72.
3. Banerjee C, Javed A, Choi JY, Green J, Rosen V, van Wijnen AJ, Stein JL, Lian JB, Stein GS. 2001. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142(9):4026-4039.
4. Bostrom K, Tsao D, Shen S, Wang Y, Demer LL. 2001. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 276:14044-14052.
5. Celil AB, Campbell PG. 2005. BMP-2 and insulin-like growth factor-1 mediate osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signalling pathways. J Biol Chem 280: 31353-31359.
6. Celil AB, Hollinger JO, Campbell PG. 2005. Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signalling. J Cell Biochem 95:518-528.
7. Chang Y-L, Stanford CM, Keller JC. 2000. Calcium and phosphate supplementation promotes bone cell mineralization: Implications for hydroxyapatite (HA)-enhanced bone formation. J Biomed Mater Res 52:270-278.
8. Cheng S, Shao J, Charlton-Kachigaian N, Lowey A, Towler D. 2003. Msx2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesencymal progenitors. J Biol Chem 278:45969-45977.
9. Chung C-H, Golub EE, Forbes E, Tokuoka T, Shapiro IM. 1992. Mechanism of action of β-glycerophosphate on bone cell mineralization. Calcif Tissue Int 51:305-311.
10. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E. 2005. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 68:429-436.
11. Dhore CR, Cleutjens JPM, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ. 2001. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arteriol Thromb Vasc Biol 21:1998-2003.
12. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89(5):747-754.
13. Engelese MA, Neele JM, Bronckers ALJJ, Pannekoek H, de Vries CJM. 2001. Vascular calcification: Expression patterns of the osteoblast-specific gene core binding factor α-1 and the protective factor matrix gla protein in human atherogenesis. Cardiovasc Res 52:281-289.
14. Fujii M, Takeda K, lmamura T, Aoki H, Sampath TK, Enomoto S, Kawabata M, Kato M, Ichijo H, Miyazono K. 1999. Roles of bone morphogenetic protein type 1 receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 10:3801-3813.
15. Gerstenfeld LC, Chipman SD, Glowacki J, Lian JB. 1987. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 122:49-60.
16. Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H. 2005. Regulation of vascular calcification: Roles of phosphate and osteopontin. Circ Res 96:717-722.
17. Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL. 1999. Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 14(9):1522-1535.
18. Hicok K, Thomas T, Gori F, Rickard D, Spelsberg T, Riggs B. 1998. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res 13:205-217.
19. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K. 1993. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 92:2814-2820.
20. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM. 2000. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10-E17.
21. Jono S, Shioi A, Ikari Y, Nishizawa Y. 2006. Vascular calcification in chronic kidney disease. J Bone Miner Metab 24:176-181.
22. Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM. 2004. BMP-2 induced ALP expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem 279:5073-5080.
23. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89(5):755-764.
24. Lee M, Kwon T, Park H, Wozney J, Ryoo H. 2003. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Comm 309:689-694.
25. Lupo G, Nicotra A, Giurdanella G, Anfuso CD, Romeo L, Biondi G, Tirolo C, Marchetti B, Ragusa N, Alberghina M. 2005. Activation of phospholipase A(2) and MAP kinases by oxidized low-density lipoproteins in immortalized GP8.39 endothelial cells. Biochem Biophys Acta 1735(2):135-150.
26. Mehrotra R, Budoff M, Hokanson JE, Ipp E, Takasu J, Adler S. 2005. Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int 68:1258-1266.
27. Nakashima K, Zhou X, Kunkl G, Zhang Z, Deng JM, Behringer RR, De Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
28. Nishio Y, Dong Y, Paris M, O'Keefe RJ, Schwarz EM, Drissi H. 2006. Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 10:62-70.
29. Nuttal ME, Patton A, Olivera D, Nadeau DP, Gowen M. 1998. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J Bone Miner Res 13:371-382.
30. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson A, Tintut Y, Berliner J, Demer LL. 1997. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. Arterioscler Thromb Vasc Biol 17:680-687.
31. Peter SJ, Liang CR, Kim DJ, Widmer MS, Mikos AG. 1998. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerophosphate, and L-ascorbic acid. J Cell Biochem 71:55-62.
32. Poliard A, Nifuji A, Lamblin D, Plee E, Forest C, Kellerman O. 1995. Controlled conversion of an immortalized mesodermal progenitor cell towards osteogenic, chondrogenic, or adipogenic pathways. J Cell Biol 130:1461-1472.
33. Robledo R, Rajan L, Li X, Lufkin T. 2002. The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev 16:1089-1101.
34. Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T, Takano Y, Uchiyama M, Heaney S, Peters H, Tang Z, Maxson R, Maas R. 2000. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 24:391-395.
35. Shanahan CM, Cary NR, Metcalfe JC, Weissberg 7L. 1994. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393-2402.
36. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H. 1995. β-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15:2003-2009.
37. Stocker R, Keaney JF. 2003. Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381-1478.
38. Tsimikas S, Witztum JL. 2000. The oxidative modification hypothesis of atherosclerosis. In: Keaney JF, editor. Oxidative stress and vascular disease. Boston: Kluwer. pp 49-74.
39. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM. 2003. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vas Biol 23:489-494.
40. Velarde VA, Jenkins J, Christopher T, Lyons A, Jaffa A. 2001. Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells. J Appl Physiol 91:412-420.
41. Villa-Bellosta R, Bogaert YE, Levi M, Sorribas V. 2007. Characterization of phosphate transport in rat vascular smooth muscle cells. Implications for vascular calcification. Arterioscler Thromb Vasc Biol 27:1030-1036.
42. Wada T, McKee MK, Steitz S, Giachelli CM. 1999. Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin. Circ Res 84:166-178.
43. Yang L, Simon RR, Osip SL, Shaughnessy SG. 2005. The effect of heparin on osteoblast differentiation and activity in primary cultures of bovine aortic smooth muscle cells. Atherosclerosis 179:79-86.
44. Zebboudj AF, Imura M, Bostrom K. 2002. Matrix GLA protein: A regulatory protein for bone morphogenetic protein-2. J Biol Chem 277:4388-4394.
45. Zebboudj AF, Shin V, Bostrom K. 2003. Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 90:756-765.